AstraZeneca vaccine: UK regulator to give update on blood clot probe
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.The UK’s medicines regulator will outline the findings of its investigation into fears the Oxford/ AstraZeneca vaccine is linked to blood clots later today.
The Medicines and Healthcare products Regulatory Agency (MHRA) has been looking into a potential association between rare blood clots in adults and the jab.
The European regulator, the European Medicines Agency (EMA), is also expected to hold a similar briefing to explain the findings of its own separate probe.
The UK press conference, to begin at 3pm, will be led by the MHRA and the government’s advisers on the use of vaccines, the JCVI.
Yesterday Oxford paused a trial of its coronavirus vaccine in children as the regulators continued their investigation.
Read more:
- Coronavirus news live: Latest AstraZeneca vaccine updates
- ‘Link’ between AstraZeneca vaccine and blood clots, EMA official says
- Trial of AstraZeneca coronavirus vaccine in children paused amid rare blood clots probe
- Are younger people at risk of blood clots linked to AstraZeneca vaccine?
- What’s the latest on the AstraZeneca vaccine and possible blood clot link?
The university made clear no problems had arisen within the trial itself.
A spokesperson said in a statement: "Whilst there are no safety concerns in the paediatric clinical trial, we await additional information from the MHRA on its review of rare cases of thrombosis/thrombocytopaenia that have been reported in adults, before giving any further vaccinations in the trial.
"Parents and children should continue to attend all scheduled visits and can contact the trial sites if they have any questions."
Yesterday a senior EMA official said he believed that there was a link between the AstraZeneca vaccine and a number of extremely rare blood clots reported in those who recently received the jab.
In an interview with Italy’sIl Messaggero newspaper, Marco Cavaleri, the head of vaccines strategy at the EMA, said it was “clear there is a link with the vaccine” but added that there was still uncertainty about what exactly was causing such a reaction.
Mr Cavaleri said that his agency had seen among younger vaccinated people a higher than expected number of cases of cerebral thrombosis – or blood clotting in the brain – compared with the general population.
Subscribe to Independent Premium to bookmark this article
Want to bookmark your favourite articles and stories to read or reference later? Start your Independent Premium subscription today.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments